The pharmaceutical industry is undergoing considerable changes in face of R&D diminished productivity, the patent cliff and increased competitiveness leading to pricing pressure.
The traditional linear approach to corporate innovation appears unable to increase pipeline value and corporate revenue. In fact, recent mergers and acquisitions, geographic expansion and diversification into consumer and animal healthcare have neither compensated for the slowdown in innovation, nor decreased the unsustainable cost of bringing new drugs to the market.
Big pharma, as a result, is moving…
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Online
Nov 14, 2024
Tokyo (Japan)
Miami, FL (USA)
Dec 4, 2024
Online
Dec 12, 2024
Seoul (South Korea)
Jan 29, 2025
Online
Mar 20, 2025
Monterey, CA (USA)
May 6, 2025
Online
Jun 19, 2025
London (UK)